André Marette
Chercheur universitaire
Axe Endocrinologie et néphrologie
Publications
View all-
article Barbe V, de Toro-Martín J, Garneau V, Couture P, Roy D, Couillard C, Marette A, Vohl MC
Functional gut microbiome signatures underlying interindividual variability in metabolic responses to red raspberry consumption
Sci Rep 16 (1), 2026.
-
article Abed Y, Rhéaume C, Carbonneau J, Fortin N, Maltais R, Marette A, Poirier D, Boivin G
Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection
Antivir Ther 30 (6), 2025.
-
article Desmarais F, Maltais R, Sancéau JY, Marcotte B, Guèvremont G, Trottier J, Mitchell PL, Barbier O, Poirier D, Marette A
A New Synthetic Analogue of Protectin DX With Enhanced Therapeutic Potential Against Metabolic-Associated Steatotic Liver Disease
FASEB J 39 (20), 2025.
Projects
- Role of altered production of branched-chain hydroxy acids (BCHA) in the pathogenesis of type 2 diabetes (T2D) and fatty liver disease and its prevention by BCHA-supplemented yogurt, from 2023-04-01 to 2028-03-31
- Nutrient sensing mechanisms underlying the metabolic effects of dietary proteins in obesity and type 2 diabetes, from 2023-10-01 to 2028-09-30
- Comparaison des effets métaboliques d’isolats protéiques de caséines et de pois et de fromages et analogues végétaux de fromages élaborés à partir de ces isolats à l'aide de modèles in vitro et in vivo humanisés, from 2024-01-01 to 2027-04-30
- Institut sur la nutrition et les aliments fonctionnels (INAF), from 2024-04-01 to 2030-03-31
- Chaire Valbiotis sur la recherche translationnelle des mécanismes d’action de composés végétaux sur la stéatose hépatique métabolique, from 2024-01-04 to 2029-01-03
- Identification of microbial biomarkers associated with semaglutide-induced weight loss response, from 2025-01-01 to 2027-03-31
- Microbial determinants of the therapeutic response to ellagitannin polyphenols for hepatic steatosis, from 2024-12-01 to 2027-03-31
- Efficacité d'une intervention basée sur le coaching parental et l'analyse de la perception sensorielle des aliments chez les enfants autiste, from 2024-12-18 to 2027-12-17
- Effects of cranberry on gut and metabolic health, from 2025-02-13 to 2027-12-31
- Une nouvelle classe d’analogues lipidiques pour la résolution des maladies hépatiques inflammatoires (Marette), from 2025-06-09 to 2027-12-31
- Une nouvelle classe d’analogues lipidiques pour la résolution des maladies hépatiques inflammatoires, from 2025-06-09 to 2027-12-31
- Role of GPR37 in the therapeutic action of protectin DX and a new synthetic analogue against type 2 diabetes and related complications, from 2026-01-01 to 2028-12-31
- Harnessing the gut microbiome-prostate cancer crosstalk and its modulation by long-chain omega-3 to discover predictive biomarkers of risk and potential preventive strategies, from 2025-11-01 to 2030-10-31
- Découverte et caractérisation d'effets de nouveaux -biotiques sur la santé cardiométabolique et neurognitive au cours du vieillissement, from 2026-03-17 to 2029-03-17
- Nanomatériaux pour cibler le microbiote intestinal et altérer le métabolisme des acides biliaires, from 2023-04-01 to 2026-03-31
- Demonstration of the prebiotic effects of camu-camu consumption against obesity-related disorders in humans, from 2023-11-01 to 2025-04-30
- Screening the functional impact of bacterial strains in the liver and adipose tissue of people with obesity and type 2 diabetes using nematode and murine models, from 2025-01-01 to 2026-03-31
- Effects of egg yolk granule fractions exposed to high hydrostatic pressure on the metabolic health of obese mice, from 2024-11-22 to 2025-11-21
- Dietary protein impact on post-prandial hepatic metabolic fluxes, from 2025-05-11 to 2025-11-11